SCHEMBL18095347

SCHEMBL18095347

CS(=O)(=O)OCCOCCOC1CCCCO1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MMP9 P14780 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
KDM4C Q9H3R0 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16334034 1.00 MEN1 (0.39) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL9139663 1.00 MEN1 (0.39) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL14213774 0.95 MEN1 (0.41) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL2750540 0.94 KDM4E (0.43) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL16012883 0.88 KDM4E (0.48) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL7746253 0.86 MEN1 (0.48) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL6680391 0.86 MEN1 (0.48) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL9533048 0.86 MEN1 (0.48) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL29487279 0.86 MEN1 (0.48) MEN1KMT2AKDM4EUSP2ALDH1A1
SCHEMBL13455405 0.83 MEN1 (0.44) MEN1KMT2ATSHRKDM4CNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567442-B Inhibitors of hepatitis C virus polymerase 共晶制药公司 2021-05-25 CN disclosed
US-10947210-B2 Inhibitors of Hepatitis C virus polymerase COCRYSTAL PHARMA, INC. (US) 2021-03-16 US disclosed
US-20200255393-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL PHARMA, INC. 2020-08-13 US disclosed
US-10464914-B2 Inhibitors of hepatitis C virus polymerase COCRYSTAL PHARMA, INC. (US) 2019-11-05 US disclosed
EP-3274340-B1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL PHARMA INC (US) 2019-07-17 EP disclosed
US-20180050998-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL PHARMA, INC. 2018-02-22 US disclosed
EP-3274340-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE Cocrystal Pharma, Inc. (US) 2018-01-31 EP disclosed
WO-2016154241-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE COCRYSTAL PHARMA, INC. (US) 2016-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255393-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE POLI, POLR2E, POLR2H MEN1 4697/4885KMT2A 3562/4885KDM4E 3514/4885
US-10464914-B2 Inhibitors of hepatitis C virus polymerase POLI, POLR2E, POLR2H MEN1 4697/4885KMT2A 3562/4885KDM4E 3514/4885
US-10947210-B2 Inhibitors of Hepatitis C virus polymerase POLI, POLR2E, POLR2H MEN1 4697/4885KMT2A 3562/4885KDM4E 3514/4885
US-20180050998-A1 INHIBITORS OF HEPATITIS C VIRUS POLYMERASE POLI, POLR2E, POLR2H MEN1 4697/4885KMT2A 3562/4885KDM4E 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.